Sponsor

Population Council

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Population Council appears in 24 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials24
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

24 shown
A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy PreventionNCT04778514 · lead sponsor · 2022-12-07
COMPLETED
A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy PreventionNCT04778527 · lead sponsor · 2022-09-13
UNKNOWN
A Crossover Study Evaluating 3 Non-medicated Silicone IVRsNCT05128136 · lead sponsor · 2022-01-20
COMPLETED
Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy WomenNCT02875119 · lead sponsor · 2017-10-01
COMPLETED
Addressing Gender Based Violence in HIV Testing and CounselingNCT02577380 · lead sponsor · 2014-06-01
COMPLETED
Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal UseNCT02033109 · lead sponsor · 2014-05-01
COMPLETED
Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV TransmissionNCT00213083 · lead sponsor · 2004-04-01
COMPLETED
A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected WomenNCT00213044 · lead sponsor · 2003-03-01
COMPLETED
Safety and Acceptability of Carraguard® in HIV Positive Women and MenNCT00213005 · lead sponsor · 2002-06-01
COMPLETED
Safety and Acceptability of Carraguard™ Among HIV-negative Couples in ThailandNCT00213057 · lead sponsor · 2001-06-01
COMPLETED
Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideNCT00213031 · lead sponsor · 2000-02-01
COMPLETED
Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI TransmissionNCT00213018 · lead sponsor · 1999-10-01
COMPLETED
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)NCT06004011 · collaborator · 2024-05-01
RECRUITING
Integrated Care Delivery of HIV Prevention and Treatment in AGYW in ZambiaNCT03995953 · collaborator · 2021-05-10
COMPLETED
Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision (EIMC) in Sub-Saharan AfricaNCT03338699 · collaborator · 2018-10-01
COMPLETED
Project YES! Youth Engaging for SuccessNCT04115813 · collaborator · 2017-12-15
COMPLETED
Universal Coverage of Antiretroviral Treatment in SenegalNCT03880006 · collaborator · 2017-06-05
COMPLETED
A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to Improve Maternal and Child Outcomes in LesothoNCT04598958 · collaborator · 2016-07-27
COMPLETED
Alcohol and ART Adherence in IndiaNCT03746457 · collaborator · 2015-05-10
COMPLETED
The TracTOR (Tracking and Tracing Operations Research) Study -- ZimbabweNCT02552693 · collaborator · 2015-03-01
COMPLETED
Supporting Attendance for Facility Delivery and Infant HealthNCT03023033 · collaborator · 2014-10-01
COMPLETED
Safety and Acceptability of the PrePex™ Device for Male Circumcision in ZambiaNCT01844102 · collaborator · 2013-10-01
COMPLETED
Enhancing HIV Risk Reduction Among Indian Women With Risky HusbandsNCT01592994 · collaborator · 2010-07-01
COMPLETED
Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and SwazilandNCT01694862 · collaborator · 2009-01-01
COMPLETED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Population Council as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

collaborator12
lead sponsor12
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.